Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 4/20 | 0.66 |
| ▸ | PGR | P06401 | 4/20 | 0.66 |
| ▸ | AR | P10275 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.66 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.66 |
| ▸ | HTR2B | P41595 | 1/20 | 0.66 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.66 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19887684 | 0.92 | NR3C1 (0.69) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL14285031 | 0.92 | NR3C1 (0.69) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL14450051 | 0.92 | NR3C1 (0.69) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL14284891 | 0.92 | NR3C1 (0.69) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL20553 | 0.92 | NR3C1 (0.69) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL13988191 | 0.88 | NR3C1 (0.74) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL14085423 | 0.87 | LMNA (0.61) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL11648054 | 0.85 | NR3C1 (0.70) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL14114621 | 0.83 | CYP3A4 (0.67) | NR3C1PGRARLMNANR3C2 | |
| SCHEMBL14499164 | 0.81 | CYP3A4 (0.63) | NR3C1PGRARLMNANR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-8715735-B2 | Stabilised supersaturated solids of lipophilic drugs | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-06 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| EP-2087883-B1 | Stabilised supersaturated solid solutions of steroidal drugs | Bayer Pharma AG (DE) | 2012-07-25 | — | — | EP | claimed |
| CN-1984644-B | Stable supersaturated solids of lipophilic drugs | BAYER SCHERING AG | 2010-12-08 | — | — | CN | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1765290-B1 | STABILISED SUPERSATURATED SOLID SOLUTIONS OF STEROIDAL DRUGS | BAYER SCHERING PHARMA AG (DE) | 2009-09-09 | — | — | EP | claimed |
| EP-2087883-A1 | Stabilised supersaturated solid solutions of steroidal drugs | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-08-12 | — | — | EP | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| CN-1984644-A | Stable supersaturated solids of lipophilic drugs | SCHERING AG (DE) | 2007-06-20 | — | — | CN | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1765290-A2 | STABILISED SUPERSATURATED SOLID SOLUTIONS OF STEROIDAL DRUGS | Schering Aktiengesellschaft (DE) | 2007-03-28 | — | — | EP | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| WO-2005087199-A2 | STABILISED SUPERSATURATED SOLID SOLUTIONS OF STEROIDAL DRUGS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-09-22 | — | — | WO | claimed |
| US-20050207990-A1 | Stabilised supersaturated solids of lipophilic drugs | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2005-09-22 | — | — | US | claimed |